The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas
- PMID: 33508895
- DOI: 10.1111/nan.12700
The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas
Abstract
Aims: Brain invasion (BI) was firstly defined as a single criterion of atypia in otherwise benign meningiomas in the revised fourth edition of 2016 WHO classification of brain tumours after being previously inconsistently addressed. However, recent studies have raised doubts about the prognostic significance of BI in otherwise benign meningiomas. In our study, we investigate the reproducibility of such a prognostic effect.
Methods: We identified two cohorts one consisting of 483 patients with meningioma WHO grade I (M°I) or atypical meningioma WHO grade II (M°II) from Hannover Medical School and the other including atypical meningiomas defined according to the classical WHO criteria (M°IIb) from the University Hospital Heidelberg. Follow-up data with a median observation time of 38.2 months were available from 308 cases. These included 243 M°I and 65 M°II patients with the latter group consisting of 25 patients with otherwise benign meningiomas with BI (M°IIa) and 40 with M°IIb.
Results: A significant difference of progression-free interval (PFI) was found between patients with M°I and M°II, M°I and M°IIa and those with M°I and M°IIb of both cohorts and each separately. However, PFI of M°IIa and M°IIb patients showed no significant difference. In the multivariate regression analysis adjusted for M°I/M°IIa versus M°IIb, sex, age, extent of resection and tumour location, BI exhibited the strongest risk of relapse (Hazard ratio: 4.95) serving as an independent predictor of PFI (p = 0.002).
Conclusions: Our results clearly support the definition of BI as a single criterion of atypia in WHO classification of 2016.
Keywords: WHO classification; atypia; brain invasion; meningioma.
© 2021 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
Similar articles
-
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.Brain Tumor Pathol. 2021 Apr;38(2):81-95. doi: 10.1007/s10014-020-00390-y. Epub 2021 Jan 6. Brain Tumor Pathol. 2021. PMID: 33403457
-
Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?J Neurooncol. 2018 Apr;137(2):331-336. doi: 10.1007/s11060-017-2721-4. Epub 2017 Dec 21. J Neurooncol. 2018. PMID: 29270884
-
Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.J Neurol Neurosurg Psychiatry. 2008 May;79(5):574-80. doi: 10.1136/jnnp.2007.121582. Epub 2007 Aug 31. J Neurol Neurosurg Psychiatry. 2008. PMID: 17766430
-
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.J Neurooncol. 2019 Dec;145(3):469-477. doi: 10.1007/s11060-019-03312-x. Epub 2019 Nov 11. J Neurooncol. 2019. PMID: 31713016
-
Atypical meningiomas.Handb Clin Neurol. 2020;170:233-244. doi: 10.1016/B978-0-12-822198-3.00043-4. Handb Clin Neurol. 2020. PMID: 32586495 Review.
Cited by
-
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.Neuro Oncol. 2025 Feb 10;27(2):319-330. doi: 10.1093/neuonc/noae170. Neuro Oncol. 2025. PMID: 39212325 Review.
-
LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.Mol Cells. 2022 Jun 30;45(6):388-402. doi: 10.14348/molcells.2022.2232. Mol Cells. 2022. PMID: 35680373 Free PMC article.
-
Meningiomas with CNS invasion.Front Neurosci. 2023 Jun 29;17:1189606. doi: 10.3389/fnins.2023.1189606. eCollection 2023. Front Neurosci. 2023. PMID: 37456997 Free PMC article. Review.
-
Brain Invasion in Meningioma-A Prognostic Potential Worth Exploring.Cancers (Basel). 2021 Jun 29;13(13):3259. doi: 10.3390/cancers13133259. Cancers (Basel). 2021. PMID: 34209798 Free PMC article. Review.
-
Meningioma recurrence: Time for an online prediction tool?Surg Neurol Int. 2024 May 10;15:155. doi: 10.25259/SNI_43_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 38840600 Free PMC article. Review.
References
REFERENCES
-
- Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification and Grading of Tumours of the Central Nervous System. Revised, 4th ed. Lyon: IARC Press; International Agency for Research on Cancer; 2016.
-
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Meningiomas. In: Bosman FT, Jaffe ES, Lakhani SR, Ohgak H, eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: International Agency for Research on Cancer; 2007:309.
-
- Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system, 2nd ed. Lyon: IARC Press; International Agency for Research on Cancer; 2000:314.
-
- Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997;21(12):1455-1465.
-
- Kleihues P, Burger PC, Scheithauer BW, WHO. Tumors of the meninges. In: Histological Typing of Tumours of the Central Nervous System. 2nd ed. Berlin, Heidelberg, New York: Springer Verlag; 1993:112.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical